Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 699-704

  Salminen, Eeva K ^a   Pukkala, Eero ^b   Kiel, Krys D ^c   Hakulinen, Timo T ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Cancer registry; Esophageal cancer; Radiotherapy; Second cancer

Indexed keywords

BIOLOGICAL ORGANS; BIOMEDICAL ENGINEERING; CHEMOTHERAPY; HEALTH RISKS; PATIENT TREATMENT; TUMORS;

BREAST CANCER; CANCER REGISTRY; ESOPHAGEAL CANCER; SECOND CANCER;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CLINICAL OBSERVATION; CONFIDENCE INTERVAL; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER;

AGE FACTORS; AGED; BREAST NEOPLASMS; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RISK;

EID: 33646912992     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.017     Document Type: Article

References (29)

1. http://www.cancerregistry.fi/eng/statistics.
2. Bonadonna G., Moliterni A., Zambetti M., et al. 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer. Cohort study. BMJ 330 (2005) 217-220
3. Curtis R.E., Boice J.D., Stovall M., et al. Risk of leukemia after chemotherapy and radiotherapy treatment for breast cancer. New Engl J Med 326 (1992) 1745-1751
4. Smith R.E., Bryant J., DeCillis A., et al. Acute myeloplastic leukemia and muyeloblastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer. The National Surgical Adjuvant Breast and Bowel Project. J Clin Oncol 21 (2003) 1195-1204
5. Ewertz M., and Mouridsen H.T. Second cancer following cancer of the female breast in Denmark, 1943-1980. Natl Cancer Inst Monogr 68 (1985) 325-329
6. Ahsan H., Neugut A.I., and Gammon M.D. Association of adenocarcinoma and squamous cell carcinoma of the oesophagus with tobacco related and other malignancies. Cancer Epidemiol Biomarkers Prev 6 (1997) 779-782
7. Ahsan H., and Neugut A.I. Radiation therapy for breast cancer and increased risk of oesophageal carcinoma. Ann Intern Med 128 (1998) 114-117
8. Neugut A.I., Weinberg M.D., Ashan H., et al. Carcinogenic effects of radiotherapy for breast cancer. Oncology 13 (1999) 1245-1256
9. Galper S., Gelman R., Recht A., et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Rad Onc Biol Phys 52 (2002) 406-414
10. Wright F., Wasan S., and Mercer C.D. Radiation-induced oesophageal squamous cell carcinoma in situ. Dis Oesophagus 13 (2000) 255-258
11. Sartori S., Nielsen I., Indelli M., et al. Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF). An iatrogenic injury?. Ann Intern Med 114 (1991) 210-211
12. Hakulinen T., and Teppo L. Causes of death among female patients with cancer of the breast and intestines. Ann Clin Res 9 (1977) 15-24
13. Heinävaara S., Teppo L., and Hakulinen T. Cancer-specific survival of patients with multiple cancers. An application to patients with multiple breast cancer. Stat Med 21 (2002) 3183-3195
14. Hotes J.L., Ellison L.F., Howe H.L., et al. Variation in breast cancer counts using SEER and IARC multiple primary coding rules. Cancer Causes Control 15 (2004) 185-191
15. Sankila R., Pukkala E., and Teppo L. Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953-1991. Int J Cancer 60 (1995) 464-470
16. Boice J.D., Land C.E., and Preston D.L. Ionizing radiation. In: Schottenfield D., and Fraumeni J.F. (Eds). Cancer epidemiology and prevention (1996), Oxford University Press, New York 310-341
17. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node positive breast cancer. N Engl J Med 337 (1997) 956-962
18. Harvey E.B., and Brinton L.A. Second cancer following cancer of the breast in Connecticut, 1935-1982. Natl Cancer Inst Monogr 68 (1985) 99-112
19. Halperin E.C., Smith-Ullrich R.K., Perez C.A., et al. The principles in radiation oncology. In: Perez C.A., Brady L., and Halperin E.C. (Eds). Principles and practice of radiation oncology. 4th ed. (2004), Lippincott-Williams and Wilkins, Philadelphia 69
20. Potish R., Dehner L., Haselow R., et al. The incidence of second neoplasms following megavoltage radiation for paediatric tumours. Cancer 56 (1985) 1534-1537
21. Bellon J., and Harris J. Which extent of adjuvant radiotherapy is standard?. Breast 14 Suppl (2005) S8-S9
22. Rubino C., de Vathaire F., Diallo I., et al. Increased risk of second cancers following breast cancer. Role of initial treatment. Breast Cancer Res Treat 61 (2000) 183-195
23. Levi F., Randimbison L., Te V.C., et al. Increased risk of esophageal cancer after breast cancer. Ann Oncol 16 (2005) 1829-1831
24. Zablotska L.B., Chak D., Das A., et al. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol 161 (2005) 330-337
25. Teppo L., Pukkala E., and Lehtonen M. Data quality and quality control of a population-based cancer registry. Acta Oncol 33 (1994) 365-369
26. Frodin J.E., Ericsson J., and Barlow L. Multiple primary malignant tumors in a national cancer registry. Reliability of reporting. Acta Oncol 36 (1997) 465-469
27. Salminen E., Pukkala E., and Teppo L. Second tumours in patients with brain tumours. Impact of treatment. Eur J Cancer 35 (1999) 102-105
28. Hall E.J., and Wuu C.S. Radiation induced second cancers. The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
29. Dasu A., Toma-Dasu J., Olofsson J., et al. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 44 (2005) 339-347